Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A randomized controlled trial to verify the efficacy of the use of ultrasonography in breast cancer screening aged 40-49 (J-START): 76 196 women registered.

Ishida T, Suzuki A, Kawai M, Narikawa Y, Saito H, Yamamoto S, Tohno E, Sobue T, Fukuda M, Ohuchi N.

Jpn J Clin Oncol. 2014 Feb;44(2):134-40. doi: 10.1093/jjco/hyt199.

PMID:
24407835
2.

Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.

Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, Endo T, Fukao A, Tsuji I, Yamaguchi T, Ohashi Y, Fukuda M, Ishida T; J-START investigator groups..

Lancet. 2016 Jan 23;387(10016):341-8. doi: 10.1016/S0140-6736(15)00774-6.

PMID:
26547101
3.

Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design.

Ohuchi N, Ishida T, Kawai M, Narikawa Y, Yamamoto S, Sobue T.

Jpn J Clin Oncol. 2011 Feb;41(2):275-7. doi: 10.1093/jjco/hyq214.

4.

Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.

Gartlehner G, Thaler K, Chapman A, Kaminski-Hartenthaler A, Berzaczy D, Van Noord MG, Helbich TH.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009632. doi: 10.1002/14651858.CD009632.pub2. Review.

PMID:
23633376
5.

Participants' understanding of a randomized controlled trial (RCT) through informed consent procedures in the RCT for breast cancer screening, J-START.

Shiono YN, Zheng YF, Kikuya M, Kawai M, Ishida T, Kuriyama S, Ohuchi N.

Trials. 2014 Sep 25;15:375. doi: 10.1186/1745-6215-15-375.

6.

Relative and combined performance of mammography and ultrasonography for breast cancer screening in the general population: a pilot study in Tochigi Prefecture, Japan.

Honjo S, Ando J, Tsukioka T, Morikubo H, Ichimura M, Sunagawa M, Hasegawa T, Watanabe T, Kodama T, Tominaga K, Sasagawa M, Koyama Y.

Jpn J Clin Oncol. 2007 Sep;37(9):715-20.

PMID:
17766996
7.

Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.

Miller AB, Baines CJ, To T, Wall C.

CMAJ. 1992 Nov 15;147(10):1477-88. Erratum in: Can Med Assoc J 1993 Mar 1;148(5):718.

8.
9.

Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan.

Tohno E, Umemoto T, Sasaki K, Morishima I, Ueno E.

Eur J Radiol. 2013 Aug;82(8):1227-30. doi: 10.1016/j.ejrad.2013.02.007.

PMID:
23465737
10.

Breast cancer screening by mammography in women aged under 50 years in Japan.

Morimoto T, Sasa M, Yamaguchi T, Kondo H, Akaiwa H, Sagara Y.

Anticancer Res. 2000 Sep-Oct;20(5C):3689-94.

PMID:
11268440
11.

Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.

Miller AB, Baines CJ, To T, Wall C.

CMAJ. 1992 Nov 15;147(10):1459-76. Erratum in: Can Med Assoc J 1993 Mar 1;148(5):718.

12.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

13.

Ultrasound screening of breast cancer.

Tohno E, Ueno E, Watanabe H.

Breast Cancer. 2009;16(1):18-22. doi: 10.1007/s12282-008-0082-8.

PMID:
19009372
14.

Breast screening in north India: a cost-effective cancer prevention strategy.

Pandey S, Chandravati.

Asian Pac J Cancer Prev. 2013;14(2):853-7.

15.

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.

Saadatmand S, Rutgers EJ, Tollenaar RA, Zonderland HM, Ausems MG, Keymeulen KB, Schlooz-Vries MS, Koppert LB, Heijnsdijk EA, Seynaeve C, Verhoef C, Oosterwijk JC, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MM.

BMC Cancer. 2012 Oct 2;12:440. doi: 10.1186/1471-2407-12-440.

16.

Pan-Canadian study of mammography screening and mortality from breast cancer.

Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R.

J Natl Cancer Inst. 2014 Oct 1;106(11). pii: dju261. doi: 10.1093/jnci/dju261. Erratum in: J Natl Cancer Inst. 2015 Jan;107(1):dju404 doi:10.1093/jnci/dju404.

PMID:
25274578
17.

Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.

Corsetti V, Houssami N, Ghirardi M, Ferrari A, Speziani M, Bellarosa S, Remida G, Gasparotti C, Galligioni E, Ciatto S.

Eur J Cancer. 2011 May;47(7):1021-6. doi: 10.1016/j.ejca.2010.12.002.

PMID:
21211962
18.

Changing case Order to Optimise patterns of Performance in mammography Screening (CO-OPS): study protocol for a randomized controlled trial.

Taylor-Phillips S, Wallis MG, Parsons H, Dunn J, Stallard N, Campbell H, Sellars S, Szczepura A, Gates S, Clarke A.

Trials. 2014 Jan 10;15:17. doi: 10.1186/1745-6215-15-17.

19.

Adjunct ultrasonography for breast cancer screening in women at average risk: a systematic review.

Gartlehner G, Thaler KJ, Chapman A, Kaminski A, Berzaczy D, Van Noord MG, Helbich TH.

Int J Evid Based Healthc. 2013 Jun;11(2):87-93. doi: 10.1111/1744-1609.12022. Review.

PMID:
23750571
20.

Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.

Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES; Breast Cancer Surveillance Consortium..

JAMA Intern Med. 2013 May 13;173(9):807-16. doi: 10.1001/jamainternmed.2013.307.

Supplemental Content

Support Center